Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TL02-59 is a selective inhibitor of Fgr in Src-family kinase (IC50 = 0.03 nM). TL02-59 inhibits Lyn and Hck with IC50s of 0.1 nM and 160 nM, respectively. TL02-59 potently suppresses acute myelogenous leukemia cell growth.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 25,000 | |||
5 mg | 在庫あり | ¥ 52,500 | |||
10 mg | 在庫あり | ¥ 85,500 | |||
25 mg | 在庫あり | ¥ 144,500 | |||
50 mg | 在庫あり | ¥ 206,000 | |||
100 mg | 在庫あり | ¥ 280,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 68,500 |
ターゲット&IC50 | FGR:0.03 nM , Hck:160 nM , Lyn:0.1 nM |
分子量 | 609.64 |
分子式 | C32H34F3N5O4 |
CAS No. | 1315330-17-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (196.84 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TL02-59 1315330-17-6 Angiogenesis Apoptosis Tyrosine Kinase/Adaptors Src Hck TL-02-59 Inhibitor Lyn leukemia inhibit acute orally AML TL02 59 TL0259 myelogenous Fgr inhibitor